These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1966908)

  • 1. CI-949: a new, potential antiallergy compound inhibits antigen-induced allergic reactions in guinea-pigs in vitro and in vivo.
    Adolphson RL; Thueson DO; Finkel MP; Chestnut JC; Conroy MC
    Pulm Pharmacol; 1990; 3(4):203-8. PubMed ID: 1966908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CI-959, a new, potential antiallergic drug, inhibits mediator release from lung and contractions of human airways in vitro.
    Adolphson RL; Schellenberg RR; Thueson DO; Conroy MC
    Int Arch Allergy Appl Immunol; 1990; 93(2-3):267-71. PubMed ID: 1712004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.
    Conroy MC; Kennedy JA; Chestnut JC; Wright CD; Adolphson RL; Thueson DO
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):902-8. PubMed ID: 1702129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CI-922--a novel, potent antiallergic compound--I. Inhibition of mediator release in vitro.
    Robichaud LJ; Stewart SF; Adolphson RL
    Int J Immunopharmacol; 1987; 9(1):41-9. PubMed ID: 2438238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig.
    Pretolani M; Lefort J; Silva P; Malanchere E; Dumarey C; Bachelet M; Vargaftig BB
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1259-65. PubMed ID: 2160213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy.
    Adolphson RL; Finkel MP; Robichaud LJ
    Int J Immunopharmacol; 1987; 9(1):51-60. PubMed ID: 2438239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nedocromil sodium inhibits antigen-induced contraction of human lung parenchymal and bronchial strips, and the release of sulphidopeptide-leukotriene and histamine from human lung fragments.
    Napier FE; Shearer MA; Temple DM
    Br J Pharmacol; 1990 Jun; 100(2):247-50. PubMed ID: 1696152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
    Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
    J Pharm Pharmacol; 1990 Apr; 42(4):236-41. PubMed ID: 1974289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TMK688, a novel anti-allergic drug, on allergic nasal obstruction and exudative responses in sensitized guinea pigs.
    Shizawa T; Maeda K; Abe K; Ishii T; Kamitani T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):815-9. PubMed ID: 9453468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of aerosol administration of a sulfidopeptide leukotriene antagonist on bronchoconstriction induced by antigen inhalation in guinea pigs.
    Bando T; Fujimura M; Shintani H; Saito M; Kurashima K; Nishi K; Matsuda T
    Arzneimittelforschung; 1994 Jun; 44(6):754-7. PubMed ID: 8053975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel indolecarboxamidotetrazoles as potential antiallergy agents.
    Unangst PC; Connor DT; Stabler SR; Weikert RJ; Carethers ME; Kennedy JA; Thueson DO; Chestnut JC; Adolphson RL; Conroy MC
    J Med Chem; 1989 Jun; 32(6):1360-6. PubMed ID: 2470904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiallergy activity of Sch 37224, a new inhibitor of leukotriene formation.
    Kreutner W; Sherwood J; Sehring S; Rizzo C; Chapman RW; Siegel MI; Egan RW
    J Pharmacol Exp Ther; 1988 Dec; 247(3):997-1003. PubMed ID: 2462630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.
    Kusner EJ; Buckner CK; Dea DM; DeHaas CJ; Marks RL; Krell RD
    Eur J Pharmacol; 1994 May; 257(3):285-92. PubMed ID: 7522174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The symptomatic therapy of allergic rhinitis].
    Albegger K
    Laryngorhinootologie; 1990 Dec; 69(12):613-20. PubMed ID: 1963061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
    Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
    Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of obstructive airway diseases. IV: medications with anti-allergic and anti-inflammatory action].
    Ukena D; Schlimmer P; Vogt J; Sybrecht GW
    Med Klin (Munich); 1990 Jul; 85(7):440-2. PubMed ID: 2166896
    [No Abstract]   [Full Text] [Related]  

  • 20. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.